C/EBPβ-dependent autophagy inhibition hinders NK cell function in cancer

Federica Portale1, Roberta Carriero2, Marta Iovino1

  • 1IRCCS Humanitas Research Hospital, Tumor Microenviroment Unit, 20089, Via Manzoni 56, Rozzano, Milan, Italy.

Nature Communications
|November 28, 2024
PubMed

Insights

This study reveals that autophagy regulates Natural Killer (NK) cell anti-tumor function. Activating autophagy enhances NK cell activity, offering a new strategy to improve cancer immunotherapies.

Area of Science:

  • Immunology
  • Cancer Biology
  • Cellular Metabolism

Background:

  • Natural Killer (NK) cells possess tumor-killing capabilities, but cancer often impairs their function, limiting the efficacy of cell-based therapies in solid tumors.
  • Understanding how cancers suppress NK cell activity is crucial for developing effective immune-therapies.
  • Autophagy, a cellular degradation process, has emerged as a potential regulator of immune cell function.

Purpose of the Study:

  • To investigate the role of autophagy in regulating NK cell anti-tumor function in the context of cancer.
  • To identify the molecular mechanisms by which cancer impairs NK cell activity.
  • To explore autophagy modulation as a therapeutic strategy to enhance NK cell-based cancer immunotherapies.

Main Methods:

  • Differential gene expression analysis (scRNA-seq) of tumor-infiltrating versus non-tumor NK cells from prostate cancer patients.
  • Flow cytometry validation in human patients and murine cancer models.
  • Investigation of the mechanistic link between cancer exposure, autophagy, mitochondrial function, and NK cell effector functions.
  • Assessment of the impact of inhibiting or activating autophagy on NK cell activity and tumor control.

Main Results:

  • Deregulation of the autophagic pathway was observed in tumor-infiltrating NK cells compared to non-tumor NK cells.
  • Exposure to cancer deregulated autophagy, decreased mitochondrial polarization, and impaired NK cell effector functions.
  • CCAAT enhancer binding protein beta (C/EBPβ), regulated by CXCL12-CXCR4, was identified as a key regulator of NK cell metabolism.
  • Inhibition of CXCR4 and C/EBPβ restored NK cell fitness, while autophagy activation improved NK cell effector and cytotoxic functions, leading to tumor control.

Conclusions:

  • Autophagy acts as an intracellular checkpoint controlling NK cell anti-tumor functions.
  • Targeting autophagy presents a promising approach to enhance the efficacy of NK cell-based immunotherapies for cancer treatment.

Related Concept Videos

Cells of the Innate Immune Response01:28

Cells of the Innate Immune Response

The innate immune response is an immediate and non-specific response against pathogens, acting swiftly to prevent the spread of infections. The primary cells involved in this response are phagocytes and natural killer (NK) cells.
Phagocytes
Phagocytes police the peripheral tissues by removing cellular debris and responding to the invasion of foreign substances or pathogens. Many phagocytes attack and remove microorganisms even before lymphocytes detect them. The human body has two general...
1.5K
Cytotoxic T Cells-mediated Immune Response01:27

Cytotoxic T Cells-mediated Immune Response

Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
849
Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
4.7K
Receptor Downregulation in MVBs01:15

Receptor Downregulation in MVBs

Multivesicular bodies (MVBs) are mature endosomes that sort ubiquitinated proteins and then fuse with lysosomes to degrade the sorted proteins. Epidermal growth factor (EGF) and its receptor (EGFR) form a complex that can be internalized through endocytosis, sorted into an MVB, and later degraded.
The EGFR can initiate signaling pathways that  lead to cell proliferation, migration, and differentiation. Overexpression of EGFR  stimulates cells to proliferate. Excessive  EGFR...
2.0K
NF-κB-dependent Signaling Pathway02:26

NF-κB-dependent Signaling Pathway

The transcription factor NF-κB was discovered in 1986 in the lab of Nobel laureate Professor David Baltimore, for its interaction with the immunoglobulin light chain enhancer in B-cells. After more than three decades of study, it is now evident that NF-κB regulates the expression of over 100 genes. Most of these genes play an essential role in the innate and adaptive immune responses as well as the inflammatory responses of animals.
NF-κB-dependent Signaling Mechanism
The...
7.2K
The Intrinsic Apoptotic Pathway01:31

The Intrinsic Apoptotic Pathway

Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
6.4K